These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35676014)

  • 1. Oral glucose tolerance testing as a complement to fasting plasma glucose in screening for type 2 diabetes: population-based cross-sectional analyses of 146 000 health examinations in Västerbotten, Sweden.
    Rosén A; Otten J; Stomby A; Vallin S; Wennberg P; Brunström M
    BMJ Open; 2022 Jun; 12(6):e062172. PubMed ID: 35676014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired glucose regulation in adults in Jamaica: who should have the oral glucose tolerance test?
    Sargeant LA; Boyne MS; Bennett FI; Forrester TE; Cooper RS; Wilks RJ
    Rev Panam Salud Publica; 2004 Jul; 16(1):35-42. PubMed ID: 15333264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
    Henninger J; Hammarstedt A; Rawshani A; Eliasson B
    BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil.
    Schmidt MI; Bracco PA; Yudkin JS; Bensenor IM; Griep RH; Barreto SM; Castilhos CD; Duncan BB
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):267-277. PubMed ID: 30803929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.
    Franciosi M; De Berardis G; Rossi MC; Sacco M; Belfiglio M; Pellegrini F; Tognoni G; Valentini M; Nicolucci A
    Diabetes Care; 2005 May; 28(5):1187-94. PubMed ID: 15855587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting plasma glucose is not sufficient to detect ongoing glucose intolerance after pregnancy complicated by gestational diabetes.
    Kakad R; Anwar A; Dyer P; Webber J; Dale J
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):234-6. PubMed ID: 20162508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A screening procedure detecting high-yield candidates for OGTT. The Women's Health in the Lund Area (WHILA) study: a population based study of middle-aged Swedish women.
    Lidfeldt J; Nerbrand C; Samsioe G; Scherstén B; Agardh CD
    Eur J Epidemiol; 2001; 17(10):943-51. PubMed ID: 12188015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life for pre-diabetic states and type 2 diabetes mellitus: a cross-sectional study in Västerbotten Sweden.
    Neumann A; Schoffer O; Norström F; Norberg M; Klug SJ; Lindholm L
    Health Qual Life Outcomes; 2014 Oct; 12():150. PubMed ID: 25342083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irish diabetes detection programme in general practice.
    Smith SM; Holohan J; McAuliffe A; Firth RG
    Diabet Med; 2003 Sep; 20(9):717-22. PubMed ID: 12925050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
    Adam JM; Tarigan NP
    Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].
    Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D
    Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional differences of undiagnosed type 2 diabetes and prediabetes prevalence are not explained by known risk factors.
    Tamayo T; Schipf S; Meisinger C; Schunk M; Maier W; Herder C; Roden M; Nauck M; Peters A; Völzke H; Rathmann W
    PLoS One; 2014; 9(11):e113154. PubMed ID: 25402347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance tests.
    Brohall G; Behre CJ; Hulthe J; Wikstrand J; Fagerberg B
    Diabetes Care; 2006 Feb; 29(2):363-7. PubMed ID: 16443888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for impaired glucose tolerance in obese children and adolescents: a validation and implementation study.
    Morandi A; Maschio M; Marigliano M; Miraglia Del Giudice E; Moro B; Peverelli P; Maffeis C
    Pediatr Obes; 2014 Feb; 9(1):17-25. PubMed ID: 23296488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes.
    Chou P; Li CL; Wu GS; Tsai ST
    Diabetes Care; 1998 Jul; 21(7):1183-7. PubMed ID: 9653617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
    Hage C; Lundman P; Rydén L; Mellbin L
    Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.